Castle Biosciences Shares New Data Demonstrating Ability of TissueCypher® Test Results to Inform Clinical Decision-Making in Patients with Non-Dysplastic Barrett's Esophagus
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #Barrettsesophagus--New data shows the ability of TissueCypher® test results to inform clinical decis...
October 2, 2023
11:00 AM
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #Barrettsesophagus--New data shows the ability of TissueCypher® test results to inform clinical decision-making in patients with non-dysplastic Barrett's esophagus.